Aura-C

is designed to detect early signs of cervical cancer before symptoms appear using DNA methylation.

Learn More

When to Choose

Aura-C™?

 

Ideal for women at risk of cervical cancer, especially those who test positive for high risk HPV types

Download Our Guide

Aura-C™ Non-Invasive Health cars journey for Cervical Cancer Screening

Step 01

Order my test

Order your non-invasive kit online or through your provider. You’ll receive an activation ID for tracking and secure results access.

Step 02

Self-Collection

Use the provided brush or swab to collect cervical cells. Follow the instructions for a quick, easy, at-home process.

Step 03

Drop-off Sample

Drop off the sample at a diagnostic facility or return it using the provided packaging.

Your sample will be analyzed for cervical cancer and other abnormalities.

Why Aura-C™? is a Game-Changer for Women’s Health:

Non-Invasive Sample Collection:

Uses exfoliated cervical cells; no need for tissue biopsy at screening stage.

Early Detection of CIN2+ and CIN3+:

Identifies high-grade lesions that may be missed by cytology.

DNA Methylation-Based Assay:

Targets clinically validated markers (PAX1 & JAM3) for high sensitivity and specificity.

High Clinical Accuracy:

96.5%
89.6%
CIN2+
87.09%
95.96%
CIN3+

Efficient Triage Tool:

Reduces unnecessary colposcopies and overtreatment.

CE-IVD Certified:

Approved for clinical use.

CE IVD

ESMO Clinical Trial Insights

Methylation Testing in Over 10,000 Women Shows PAX1/JAM3 as Superior Early Detection Tool for High-Risk HPV and Cervical Precancerous Lesions.

Clinical Studies

What You Receive

Results Online

Access your test results securely via our portal using your activation ID.

Gynecology Consultation

Get a personalized consultation with a gynecologist to discuss your results and next steps.

Further Screening or Treatment

If needed, you’ll receive recommendations for additional screening or treatment.